{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:29Z","timestamp":1786118789131,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Oncology"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1097\/00001622-199805000-00014","type":"journal-article","created":{"date-parts":[[2007,7,12]],"date-time":"2007-07-12T05:08:58Z","timestamp":1184216938000},"page":"261-265","source":"Crossref","is-referenced-by-count":20,"title":["Renal cell carcinoma"],"prefix":"10.1097","volume":"10","author":[{"given":"Paul A.","family":"Godley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001622-199805000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:46:27Z","timestamp":1786034787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-199805000-00014"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1097\/00001622-199805000-00014","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}